Skip to main content
Top
Published in: International Journal of Clinical Oncology 1/2024

Open Access 28-10-2023 | Trastuzumab Deruxtecan | Correction

Correction to: Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan

Authors: Tomohisa Baba, Masahiko Kusumoto, Terufumi Kato, Yasuyuki Kurihara, Shinichi Sasaki, Katsunori Oikado, Yoshinobu Saito, Masahiro Endo, Yutaka Fujiwara, Hirotsugu Kenmotsu, Masafumi Sata, Toshimi Takano, Ken Kato, Koji Hirata, Tomomi Katagiri, Hanako Saito, Kazuyoshi Kuwano

Published in: International Journal of Clinical Oncology | Issue 1/2024

Login to get access

Excerpt

Correction to: International Journal of Clinical Oncology https://doi.org/10.1007/s10147-023-02414-x
Metadata
Title
Correction to: Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan
Authors
Tomohisa Baba
Masahiko Kusumoto
Terufumi Kato
Yasuyuki Kurihara
Shinichi Sasaki
Katsunori Oikado
Yoshinobu Saito
Masahiro Endo
Yutaka Fujiwara
Hirotsugu Kenmotsu
Masafumi Sata
Toshimi Takano
Ken Kato
Koji Hirata
Tomomi Katagiri
Hanako Saito
Kazuyoshi Kuwano
Publication date
28-10-2023
Publisher
Springer Nature Singapore
Published in
International Journal of Clinical Oncology / Issue 1/2024
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-023-02427-6

Other articles of this Issue 1/2024

International Journal of Clinical Oncology 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine